Dean K. Smith, Ph.D., is an Advisor to the Director and Sr. Evaluator in the Center for Vaccines, Clinical Trials and Biostatistics at Health Canada. He has over 25-years of experience in research and regulatory science. He is active in the development / implementation of related guidance, and has a wide range of biologics-based scientific and regulatory experience from his Sr. Scientific Evaluator and management roles in Centre Divisions including Viral and Bacterial Vaccines, Hemostatic Agents & Blood Substitutes, as well as the Clinical Evaluation Division-COVID.
Representing Health Canada, Dr. Smith contributes to WHO’s vaccine and vaccine stability guidance development initiatives and supports WHO’s recent efforts with COVID-19 and Monkeypox vaccine responses. He is Health Canada’s representative to the European Directorate of Quality of Medicines (EDQM), Group 15 (Vaccines and Sera) in support of the European Pharmacopeia, the Regulatory Advisory Committee to the WHO/Collation for Emergency Preparedness and Innovation (CEPI) and served on the Science and Ethics Advisory Committee for VAC2VAC under the European Vaccines Initiative.
Dr. Smith's Ph.D. in Immunology is from the University of Alberta, Canada, where his research dealt with vaccine antigen discovery, autoimmunity and viral vector-based gene therapy. He was a Research Associate at the National Research Council’s Institute of Biological Science, Vaccine Design Group in Ottawa prior to joining Health Canada.